🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07705646
Starting soon Not applicable

Comparison of Different Ventilation Modes for Reducing Kidney Motion During Retrograde Intrarenal Surgery

NCT07705646 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-15
Last updated
2026-07-15

Condition(s) studied

Kidney StonesNephrolithiasis

Investigational drug(s) / intervention(s)

Standard VentilationHypoventilationIntermittent Apnea VentilationOne-Lung Ventilation

Standard Ventilation: Volume-controlled mechanical ventilation using standard ventilator settings during general anesthesia.

Hypoventilation: Volume-controlled mechanical ventilation using reduced tidal volume and respiratory rate during general anesthesia.

Intermittent Apnea Ventilation: Intermittent apnea periods applied during selected stages of retrograde intrarenal surgery to reduce kidney motion.

One-Lung Ventilation: One-lung ventilation applied during selected stages of retrograde intrarenal surgery to reduce kidney motion.

Study summary

This randomized clinical trial will compare four ventilation strategies during retrograde intrarenal surgery performed under general anesthesia. The study aims to determine whether reducing respiratory-related kidney movement improves surgical success and decreases perioperative complications. Eighty adult patients will be randomly assigned to standard ventilation, hypoventilation, intermittent apnea ventilation, or one-lung ventilation. Surgical outcomes and perioperative complications will be compared between groups.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: Age 18-75 years. ASA physical status I-III. Scheduled for elective RIRS/RIRC under general anesthesia. No obstructive or restrictive pulmonary disease. No history of pneumothorax. No pulmonary mass or other significant respiratory disease. Normal coagulation parameters and not receiving antithrombotic therapy. No active urinary tract infection. Written informed consent. Exclusion Criteria: Age \<18 or \>75 years. ASA IV. Obstructive or restrictive pulmonary disease. History of pneumothorax. Pulmonary mass or significant respiratory disease. Receiving antithrombotic therapy or abnormal coagulation. Active urinary tract infection or urinary tract anatomical abnormality. Refusal or inability to provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sultan Abdulhamid Han Training and Research Hospital Istanbul Istanbul

More Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07705646 on ClinicalTrials.gov ↗ ← All trials in Turkey